Involvement of Splicing Factor-1 in β-Catenin/T-Cell Factor-4-Mediated Gene Transactivation and Pre-mRNA Splicing

Gastroenterology

Volumn 132, Issue 3, 2007, Pages 1039-1054

  Shitashige, Miki ^a   Naishiro, Yasuyoshi ^a,b   Idogawa, Masashi ^a,b   Honda, Kazufumi ^a   Ono, Masaya ^a   Hirohashi, Setsuo ^a   Yamada, Tesshi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM ION; COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GENE PRODUCT; ISOTOPE; MESSENGER RNA; PEPTIDE; PROTEIN 1V; SPLICING FACTOR 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; FEMALE; GENE CONTROL; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; INTESTINE EPITHELIUM CELL; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RNA SPLICING; TRANSACTIVATION;

EID: 33947302281     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.01.007     Document Type: Article

References (54)

1. Peifer M., and Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 287 (2000) 1606-1609
2. Moon R.T., Bowerman B., Boutros M., and Perrimon N. The promise and perils of Wnt signaling through β-catenin. Science 296 (2002) 1644-1646
3. van Es J.H., Barker N., and Clevers H. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr Opin Genet Dev 13 (2003) 28-33
4. Nusse R. Wnt signaling in disease and in development. Cell Res 15 (2005) 28-32
5. Kikuchi A. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci 94 (2003) 225-229
6. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat Med 10 (2004) 789-799
7. Aberle H., Bauer A., Stappert J., Kispert A., and Kemler R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16 (1997) 3797-3804
8. Salomon D., Sacco P.A., Roy S.G., Simcha I., Johnson K.R., Wheelock M.J., and Ben-Ze'ev A. Regulation of β-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system. J Cell Biol 139 (1997) 1325-1335
9. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
10. Nakamura Y., Nishisho I., Kinzler K.W., Vogelstein B., Miyoshi Y., Miki Y., Ando H., Horii A., and Nagase H. Mutations of the adenomatous polyposis coli gene in familial polyposis coli patients and sporadic colorectal tumors. Princess Takamatsu Symp 22 (1991) 285-292
11. Sparks A.B., Morin P.J., Vogelstein B., and Kinzler K.W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 58 (1998) 1130-1134
12. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., and Kinzler K.W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275 (1997) 1787-1790
13. Munemitsu S., Albert I., Rubinfeld B., and Polakis P. Deletion of an amino-terminal sequence stabilizes β-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol Cell Biol 16 (1996) 4088-4094
14. -/- colon carcinoma. Science 275 (1997) 1784-1787
15. Naishiro Y., Yamada T., Idogawa M., Honda K., Takada M., Kondo T., Imai K., and Hirohashi S. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic β-catenin protein. Oncogene 24 (2005) 3141-3153
16. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., Tjon-Pon-Fong M., Moerer P., van den Born M., Soete G., Pals S., Eilers M., Medema R., and Clevers H. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 (2002) 241-250
17. Wong N.A., and Pignatelli M. β-catenin-a linchpin in colorectal carcinogenesis?. Am J Pathol 160 (2002) 389-401
18. Lin Y.M., Ono K., Satoh S., Ishiguro H., Fujita M., Miwa N., Tanaka T., Tsunoda T., Yang K.C., Nakamura Y., and Furukawa Y. Identification of AF17 as a downstream gene of the β-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis. Cancer Res 61 (2001) 6345-6349
19. Yamada T., Takaoka A.S., Naishiro Y., Hayashi R., Maruyama K., Maesawa C., Ochiai A., and Hirohashi S. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis. Cancer Res 60 (2000) 4761-4766
20. Aebersold R., and Mann M. Mass spectrometry-based proteomics. Nature 422 (2003) 198-207
21. Sato S., Idogawa M., Honda K., Fujii G., Kawashima H., Takekuma K., Hoshika A., Hirohashi S., and Yamada T. β-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. Gastroenterology 129 (2005) 1225-1236
22. Venables J.P. Aberrant and alternative splicing in cancer. Cancer Res 64 (2004) 7647-7654
23. Goldstrohm A.C., Albrecht T.R., Sune C., Bedford M.T., and Garcia-Blanco M.A. The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol Cell Biol 21 (2001) 7617-7628
24. Honda K., Yamada T., Hayashida Y., Idogawa M., Sato S., Hasegawa F., Ino Y., Ono M., and Hirohashi S. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 128 (2005) 51-62
25. Naishiro Y., Yamada T., Takaoka A.S., Hayashi R., Hasegawa F., Imai K., and Hirohashi S. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of β-catenin/T-cell factor 4-mediated gene transactivation. Cancer Res 61 (2001) 2751-2758
26. Hallier M., Lerga A., Barnache S., Tavitian A., and Moreau-Gachelin F. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J Biol Chem 273 (1998) 4838-4842
27. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., and Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 268 (1995) 1766-1769
28. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17 (1999) 994-999
29. Seike M., Kondo T., Mori Y., Gemma A., Kudoh S., Sakamoto M., Yamada T., and Hirohashi S. Proteomic analysis of intestinal epithelial cells expressing stabilized β-catenin. Cancer Res 63 (2003) 4641-4647
30. Toda T., Iida A., Miwa T., Nakamura Y., and Imai T. Isolation and characterization of a novel gene encoding nuclear protein at a locus (D11S636) tightly linked to multiple endocrine neoplasia type 1 (MEN1). Hum Mol Genet 3 (1994) 465-470
31. Korinek V., Barker N., Moerer P., van Donselaar E., Huls G., Peters P.J., and Clevers H. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19 (1998) 379-383
32. Roose J., and Clevers H. TCF transcription factors: molecular switches in carcinogenesis. Biochim Biophys Acta 1424 (1999) M23-M37
33. Su L.K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A.R., Luongo C., Gould K.A., and Dove W.F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256 (1992) 668-670
34. Sasahara Y., Mutoh M., Takahashi M., Fukuda K., Tanaka N., Sugimura T., and Wakabayashi K. Suppression of promoter-dependent transcriptional activity of inducible nitric oxide synthase by sodium butyrate in colon cancer cells. Cancer Lett 177 (2002) 155-161
35. Crozat A., Aman P., Mandahl N., and Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363 (1993) 640-644
36. Rabbitts T.H., Forster A., Larson R., and Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4 (1993) 175-180
37. Liu Z., Luyten I., Bottomley M.J., Messias A.C., Houngninou-Molango S., Sprangers R., Zanier K., Kramer A., and Sattler M. Structural basis for recognition of the intron branch site RNA by splicing factor 1. Science 294 (2001) 1098-1102
38. Tanaka S., Sugimachi K., Kameyama T., Maehara S., Shirabe K., Shimada M., Wands J.R., and Maehara Y. Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma. Hepatology 37 (2003) 1122-1129
39. Jang J.H., Shin K.H., Park Y.J., Lee R.J., McKeehan W.L., and Park J.G. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer. Cancer Res 60 (2000) 4049-4052
40. Gayet J., Zhou X.P., Duval A., Rolland S., Hoang J.M., Cottu P., and Hamelin R. Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20 (2001) 5025-5032
41. Jass J.R., Whitehall V.L., Young J., and Leggett B.A. Emerging concepts in colorectal neoplasia. Gastroenterology 123 (2002) 862-876
42. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., and Issa J.P. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96 (1999) 8681-8686
43. Lynch H.T., and de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36 (1999) 801-818
44. Yamada T., Mori Y., Hayashi R., Takada M., Ino Y., Naishiro Y., Kondo T., and Hirohashi S. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice. Cancer Res 63 (2003) 895-901
45. Amson R.B., Nemani M., Roperch J.P., Israeli D., Bougueleret L., Le Gall I., Medhioub M., Linares-Cruz G., Lethrosne F., Pasturaud P., Piouffre L., Prieur S., Susini L., Alvaro V., Millasseau P., Guidicelli C., Bui H., Massart C., Cazes L., Dufour F., Bruzzoni-Giovanelli H., Owadi H., Hennion C., Charpak G., Telerman A., et al. Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci U S A 93 (1996) 3953-3957
46. Cattaruzza M., Schafer K., and Hecker M. Cytokine-induced down-regulation of zfm1/splicing factor-1 promotes smooth muscle cell proliferation. J Biol Chem 277 (2002) 6582-6589
47. Consortium IHGS. Finishing the euchromatic sequence of the human genome. Nature 431 (2004) 931-945
48. Castellani P., Siri A., Rosellini C., Infusini E., Borsi L., and Zardi L. Transformed human cells release different fibronectin variants than do normal cells. J Cell Biol 103 (1986) 1671-1677
49. Chin L., Pomerantz J., and DePinho R.A. The INK4a/ARF tumor suppressor: one gene-two products-two pathways. Trends Biochem Sci 23 (1998) 291-296
50. Hirohashi S., and Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 94 (2003) 575-581
51. Honda K., Yamada T., Seike M., Hayashida Y., Idogawa M., Kondo T., Ino Y., and Hirohashi S. Alternative splice variant of actinin-4 in small cell lung cancer. Oncogene 23 (2004) 5257-5262
52. Inoue S., Ogawa S., Horie K., Hoshino S., Goto W., Hosoi T., Tsutsumi O., Muramatsu M., and Ouchi Y. An estrogen receptor β isoform that lacks exon 5 has dominant negative activity on both ERα and ERβ. Biochem Biophys Res Commun 279 (2000) 814-819
53. Hayashida Y., Honda K., Idogawa M., Ino Y., Ono M., Tsuchida A., Aoki T., Hirohashi S., and Yamada T. E-cadherin regulates the association between β-catenin and actinin-4. Cancer Res 65 (2005) 8836-8845
54. Idogawa M., Yamada T., Honda K., Sato S., Imai K., and Hirohashi S. Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/β-catenin complex. Gastroenterology 128 (2005) 1919-1936